This announcement is a separate document:
開拓藥業-B：自願公告 GT20029中國I期臨床試驗完成受試者入組給藥
KINTOR PHARMA-B: VOLUNTARY ANNOUNCEMENT COMPLETION OF SUBJECT ENROLMENT AND DOSING IN PHASE I CLINICAL TRIAL OF GT20029 IN CHINA
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.